Glow LifeTechFRA:9DO +18.18% Days Payable is 423.44 as of Mar. 2026, which is 69% below its 10-year median of 1,351.99. The stock has 1 warning sign investors should review. Among 702 Biotechnology companies, Glow LifeTech ranks better than 78.21% on this metric.
The historical rank and industry rank for Glow LifeTech's Days Payable or its related term are showing as below:
FRA:9DO'
s Days Payable Range Over the Past 10 Years
Min: 466.26 Med: 1351.99 Max: 14670.97
Current: 466.26
During the past 7 years, Glow LifeTech's highest Days Payable was 14670.97. The lowest was 466.26. And the median was 1351.99.
FRA:9DO's Days Payable is ranked better than 78.21% of 702
companies
in the Biotechnology industry
Industry Median: 113.56
vs FRA:9DO: 466.26
Glow LifeTech's Days Payable
declined
from Mar. 2025 (435.87) to Mar. 2026 (423.44).
It may suggest that Glow LifeTechaccelerated paying its suppliers.
Glow LifeTech Days Payable Related Terms
Glow LifeTech Days Payable Historical Data
* Premium members only.
The historical data trend for Glow LifeTech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:9DO vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Glow LifeTech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glow LifeTech Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Glow LifeTech's Days Payable distribution charts can be found below:
* The bar in red indicates where Glow LifeTech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Glow LifeTech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glow LifeTech (FRA:9DO) has a Days Payable of 423.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Glow LifeTech and its competitors. This is 69% below median its historical median of 1,351.99. Over the past decade, Glow LifeTech's Days Payable has ranged from 466.26 to 14,670.97. According to the industry distribution chart, Glow LifeTech ranks #153 out of 702 companies in the Biotechnology industry, placing it in the top 21.8%.
Is Glow LifeTech's Days Payable too high?
Glow LifeTech's current Days Payable of 423.44 is 69% below median its 10-year median of 1,351.99. Over the past 10 years, this metric has ranged from a low of 466.26 to a high of 14,670.97. The Biotechnology industry median Days Payable is 113.56. Glow LifeTech's value of 423.44 is 272.9% above this industry median. Based on the distribution chart, Glow LifeTech ranks #153 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Glow LifeTech's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Glow LifeTech ranks #153 out of 702 companies for Days Payable. This places Glow LifeTech in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Glow LifeTech's value of 423.44 is 272.9% above this benchmark. Historically, Glow LifeTech's own Days Payable has ranged from 466.26 to 14,670.97 over the past decade. While the company's 10-year median is 1,351.99 vs. the industry median of 113.56, Glow LifeTech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glow LifeTech's current Days Payable of 423.44 is 272.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Glow LifeTech and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glow LifeTech's current Days Payable is 423.44, which is 69% below median its own 10-year median of 1,351.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glow LifeTech stock overvalued right now?
Glow LifeTech (FRA:9DO) has a current Days Payable of 423.44. The current Days Payable is 423.44, which is 69% below median its 10-year median of 1,351.99 and 272.9% above the Biotechnology industry median of 113.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Glow LifeTech (FRA:9DO), the current Days Payable is 423.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glow LifeTech Corp is a biotechnology company engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9DO has been successfully added to your 